SEC Form 4 · accession 0001140361-17-002000
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve LaPorte
Director
Period of report
Jan 13, 2017
Accepted (ET)
Jan 17, 2017 · 2:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 13, 2017 | M | 14,000 | $15.75 | A | 48,201 | D | |
| Common StockF1 | Jan 13, 2017 | F | 14,000 | $17.92 | D | 34,201 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $15.75 | Jan 13, 2017 | M | 14,000 | D | Aug 3, 2011 | Aug 3, 2017 | Common Stock | 14,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.89 to $17.99, inclusive. The options exercised to purchase the shares were granted on 8/3/2010 and were set to expire on 8/3/2017. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.
- F2The options became exercisable as to 4,667 shares on August 3, 2011, 4,667 shares on August 3, 2012 and 4,666 shares on August 3, 2013.